Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.43 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.38 |
| ▸ | PPARA | Q07869 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5258394 | 0.81 | FDPS (0.44) | LMNACYP2D6FDPSALDH1A1CYP2C9 | |
| SCHEMBL3420449 | 0.81 | SLC6A2 (0.44) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| SCHEMBL21019385 | 0.80 | SLC6A2 (0.47) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| SCHEMBL31326889 | 0.78 | SLC6A2 (0.45) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| SCHEMBL31326890 | 0.78 | SLC6A2 (0.45) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| SCHEMBL97086 | 0.78 | TSHR (0.47) | ALDH1A1TDP1SMN1; SMN2NPSR1TSHR | |
| SCHEMBL97036 | 0.78 | TAAR1 (0.41) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| SCHEMBL1157985 | 0.76 | SLC6A2 (0.56) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| SCHEMBL3385591 | 0.76 | SLC6A2 (0.56) | SLC6A2TAAR1LMNACYP2D6CTSK | |
| Benzylamine SCHEMBL27587164 | 0.74 | LOXL2 (0.54) | SLC6A2TAAR1CYP2D6CYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118941693-A | Rendering method and device based on webpage client and electronic terminal | 网易（杭州）网络有限公司 | 2024-11-12 | — | — | CN | claimed |
| CN-1876039-B | Detection method of pharmaceutical composition for treating upper respiratory tract infection | GUIYANG YUNYAN XICHUANG PHARMACEUTICAL DEV CO LTD | 2010-11-17 | — | — | CN | claimed |
| CN-1876039-A | Pharmaceutical composition for treating upper respiratory tract infection, its preparation process and quality control method | GUIYANG YUNYAN XICHUANG PHARM (CN) | 2006-12-13 | — | — | CN | claimed |
| CN-1875999-A | Pharmaceutical preparation of bastardtoard, its preparation process and quality control method thereof | GUIYANG YUNYAN XICHUANG PHARM (CN) | 2006-12-13 | — | — | CN | claimed |
| US-20250257284-A1 | ALKYL ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2025-08-14 | — | — | US | disclosed |
| WO-2025149626-A1 | METHODS, DEVICES, AND COMPUTER PROGRAM FOR OPTIMIZING COMPRESSED REPRESENTATION OF VOLUMETRIC DATA | CANON KABUSHIKI KAISHA (JP) | 2025-07-17 | — | — | WO | disclosed |
| US-12291691-B2 | Alkyl enol ether properfume | FIRMENICH SA (CH) | 2025-05-06 | — | — | US | disclosed |
| CN-111936457-B | Enol ether pro-fragrances | 弗门尼舍有限公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-112752744-B | Alkylenol ether pro-fragrances | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250049660-A1 | ENOL ETHER PROPERFUME | FIRMENICH SA (CH) | 2025-02-13 | — | — | US | disclosed |
| CN-118941693-A | Rendering method and device based on webpage client and electronic terminal | 网易（杭州）网络有限公司 | 2024-11-12 | — | — | CN | disclosed |
| EP-4416125-A1 | ENOL ETHER PROPERFUME | Firmenich SA (CH) | 2024-08-21 | — | — | EP | disclosed |
| EP-0565132-A2 | Benzoheterocyclic compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-10-13 | — | — | EP | disclosed |
| US-5238938-A | Nephrosis | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-08-24 | — | — | US | disclosed |
| US-5225402-A | Vasopressin antagonist, vasodilation, hypotensive, diuretics and anticoagulants | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-07-06 | — | — | US | disclosed |
| EP-0513387-A1 | ACTIVE OXYGEN INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-11-19 | — | — | EP | disclosed |
| WO-1991005549-A1 | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-05-02 | — | — | WO | disclosed |
| US-4992534-A | Anticarcinogenic agents with better water solubility, low toxicity, absorption and stability | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1991-02-12 | — | — | US | disclosed |
| EP-0287951-A2 | 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
| EP-0236140-A2 | Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1987-09-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257284-A1 | ALKYL ENOL ETHER PROPERFUME | CYP2E1, ACADM, ADH5 | SLC6A2 4621/4885TAAR1 1765/4885LMNA 1108/4885 |
| US-20250049660-A1 | ENOL ETHER PROPERFUME | CYP2E1, ADH5, ECI1 | SLC6A2 3780/4885TAAR1 2605/4885LMNA 1640/4885 |
| US-12291691-B2 | Alkyl enol ether properfume | CYP2E1, ACADM, ADH5 | SLC6A2 4621/4885TAAR1 1765/4885LMNA 1108/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.